Serendipity meets precision: The integration of structure-based drug design and combinatorial chemistry for efficient drug discovery

Structure

Volumn 5, Issue 3, 1997, Pages 319-324

  Salemme, F Raymond ^a   Spurlino, John ^a   Bone, Roger ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031569368     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(97)00189-5     Document Type: Review

References (28)

1. Bugg, C.E., Carson, W.M. & Montgomery, J.A. (1993). Drugs by design. Sci. Am. 269, 60-66.
2. Weber, P.C., Wendoloski, J.J., Pantoliano, M.W. & Salemme, F.R. (1992). Crystallographic and thermodynamic comparison of natural and synthetic ligands bound to streptavidin. J. Amer. Chem. Soc. 114, 3197-3200.
3. Weber, P.C., Pantoliano, M.W., Simons, D.M. & Salemme, F.R. (1994). Structure-based design of synthetic Azobenzene ligands for streptavidin J. Amer. Chem. Soc. 116, 2717-2724
4. Wolfenden, R. (1983). Waterlogged molecules. Science 222, 1087-1093.
5. Gordon, E.M., Barrett, R.W., Dower, W.J., Fodor, S.P.A. & Gallop, M.A. (1994). Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies and future directions. J. Med. Chem. 37, 1385-1400.
6. Terrett, N.K., Gardner, M., Gordon, D., Kobylecki, R.J. & Steele, J. (1995). Combinatorial synthesis: the design of compound libraries and their application to drug discovery. Tetrahedron 51, 8135-8173.
7. Agrafiotis, D., Bone, R.F., Salemme, F.R., & Soll, R.M. (1995). System and method of automatically generating chemical compounds with desired properties, US Patent 5,463,564.
8. Kettner, C., Mersinger, L.M. & Knabb, R. (1990). Selective inhibition of thrombin by peptides of boroarginine. J. Biol. Chem. 265, 18289-18297.
9. Costanzo, M.J., et al., & Tulinsky, A. (1996). Potent thrombin inhibitors that probe the S1' subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group. J. Med. Chem. 39, 3039-3043.
10. Hilpert, K., et al., & van de Waterbeemd, H. (1994). Design and synthesis of potent and highly selective thrombin inhibitors. J. Med. Chem. 37, 3889-3901.
11. Lim, M.S.L., Johnston, E.R. & Kettner, C.A. (1993). The solution conformation of (D)Phe-Pro-containing peptides: implications on the activity of Ac-(D)Phe-Pro-boroArg-OH, a potent thrombin inhibitor. J. Med. Chem. 36, 1831-1838.
12. Kettner, C., et al., & Wexler, R. (1996). The preparation of safe thrombin inhibitors by designing compounds selective over Factor I. 212th ACS National Meeting Abstracts, Division of Medicinal Chemistry, No. 112.
13. Campbell, D.A., Bermak, J.C., Burkoth, T.S. & Patel, D.V. (1995). A transition state analog inhibitor combinatorial library. J. Am. Chem. Soc. 117, 5381-5382.
14. Kick., E.K. & Ellman, J.A. (1995). Expedient method for the solid-phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries. J. Med. Chem. 38, 1427-1430.
15. Kuntz, I.D., Meng, C.E. & Shoichet, B.K. (1994). Structure-based molecular design. Accounts Chem. Res. 27, 117-123
16. Graybill, T.L., et al., & Salemme, F.R. (1996). Enhancing the drug discovery process by integration of high-throughput chemistry and structure-based drug design. Molecular diversity and combinatorial chemistry: libraries for drug discovery. ACS Monograph, American Chemical Society, Washington, 16-27.
17. Engh, R.A., et al., & von der Saal, W. (1996) Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design. Structure 4, 1353-1362.
18. Weber, P.C., Lee, S.-L., Lewandowski, F.A., Schadt, M.C., Chang, C.-H. & Kettner, C.A. (1995). Kinetic and Crystallographic studies of thrombin with ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs. Biochemistry 34, 3750-3757
19. Obst, U., Gramlich, V., Diederich, F., Weber, L. & Banner, D.W. (1995). Design of novel nonpeptidic thrombin inhibitors and structure of a thrombin-inhibitor complex. Angew. Chem. 34, 1739-1742.
20. Mathews, I.I. & Tulinsky, A. (1995). Active-site mimetic inhibition of thrombin. Acta Cryst. D 51, 550-559.
21. Malley, M.F., et al., & Sack., J.S. (1996). Crystallographic determination of the structures of human α-thrombin complexed with BMS-186282 and BMS-189090. Protein Sci. 5, 221-228.
22. Fevig, J.M., Abelman, M.M., Bittrelli, D.R., Kettner, C.A., Knabb, R. & Weber, P.C. (1996). Design and synthesis of ring-constrained boropeptide thrombin inhibitors. Bioorg. Med. Chem. Lett. 6, 295-300.
23. Banner, D.W. & Hadvary, P. (1991). Crystallographic analysis at 3.0Å resolution of the binding to human thrombin of four active site-directed inhibitors. J. Biol. Chem. 266, 20085-20093.
24. Brown, R.D. & Martin, Y.C. (1996). Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J. Chem. Inf. Comput. Sci. 36, 572-584.
25. Martin, E.J., Spellmeyer, D.C., Critchlow, R.E. & Blaney, J.M. (1997). Does combinatorial chemistry obviate computer-aided drug design? Rev. Comput. Chem. 10, 75-100.
26. Martin, E.J., Blaney, J.M., Siani, M.A., Spellmeyer, D.C., Wong, A.K. & Moos, W.H. (1995). Measuring diversity: experimental design of combinatorial libraries for drug discovery. J. Med. Chem. 38, 1431-1441.
27. Weber, L., Wallbaum, S., Broger, C. & Gubernator, K. (1995). Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm. Angew. Chem. 34, 2280-2282.
28. Singh, J., et al., & Treasurywala, A.M. (1996). Application of genetic algorithms to combinatorial synthesis: a computational approach to lead identification and lead optimization. J. Amer. Chem. Soc. 118, 1669-1676.